In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...

More than 15% of individuals living with HIV and cancer have not received recommended first-line cancer therapy, according to results of a retrospective analysis.Among patients with HIV and cancer, ...

Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...

Kymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.

Scientists at the National Institute of Environmental Health Sciences have found that dog and cat allergens are present in ...

Hypertension, cigarette smoking, reduced high-density lipoprotein cholesterol, and HIV viral load were modifiable risk factors for primary MACE in patients with HIV on ART.

Gilead’s HIV treatment trials involving GS-1720 and GS-4182 have been put on clinical hold by the Food and Drug Administration.

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades from the South African Medical Research Council for their groundbreaking ...

In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...